Can OSPAP pharmacists do an independent prescribing course after registration?

Yes. Since the GPhC removed the old two-years-of-experience rule in 2022, entry to an accredited IP course requires relevant experience in a pharmacy setting, an identified area of clinical practice to base your learning on, and a Designated Prescribing Practitioner (DPP) to supervise at least 90 hours of learning in practice. Experience from your foundation year and patient-facing work counts.

Do you still need two years of experience for a pharmacist prescribing course?

No. The GPhC scrapped the fixed two-year requirement in May 2022. Course providers now assess the quality of your experience rather than counting years — foundation training, clinical patient-facing work, medication reviews and recent CPD all count as evidence.

Will OSPAP itself include prescribing in the future?

The GPhC has proposed replacing the current OSPAP-plus-foundation route with a single integrated year that includes independent prescribing, with a consultation from April 2026 and implementation possibly from 2028. Nothing changes for OSPAP courses before September 2026 at the earliest, and the proposal is not yet confirmed.

Does the 2026 change make OSPAP a worse option?

No — OSPAP remains the only confirmed route to UK registration for non-EEA-trained pharmacists, and registering in 2027 without prescribing still beats waiting until 2028+ for a reformed route that is not guaranteed. The change simply means overseas pharmacists should treat the IP course as part two of their plan rather than an optional extra.

Why does the prescriber annotation matter for jobs?

Independent prescribing enters the community pharmacy contract in England in 2026/27, extending Pharmacy First and the contraception service from autumn 2026. As those services scale, employers will increasingly prefer — and eventually require — prescriber-annotated pharmacists for community, PCN and clinical NHS roles, and prescribers already command stronger rates and banding.

ospap

Pharmacists Now Register as Prescribers: What Summer 2026 Means for OSPAP Graduates

Q: Do OSPAP graduates become independent prescribers when they register?

No. Independent prescribing at registration applies to graduates of MPharm degrees taught under the GPhC's 2021 initial education and training standards, whose prescribing training runs through the degree and the foundation year. OSPAP graduates complete foundation training against modified learning outcomes and join the register as pharmacists without the prescriber annotation. They can add it through an accredited post-registration course.

Abdullah Latif 8 August 2026 8 min read pharmacist independent prescriber 2026, newly qualified pharmacist prescriber, ospap independent prescribing

This summer marks the biggest change to the entry point of the UK pharmacy profession in a generation. For the first time, the majority of pharmacists joining the GPhC register will be independent prescribers from their first day of registration. The General Pharmaceutical Council has just published dedicated advice for this first cohort — trained end-to-end under its 2021 education standards — and around four in five candidates passed the June 2026 registration assessment that stands between them and the register.

For UK-trained graduates, this is a milestone. For overseas pharmacists coming through the OSPAP route, it quietly redraws the competitive map: OSPAP graduates do not receive the prescriber annotation at registration. That gap — what it means, how big it really is, and exactly how to close it — is what this article is about.

The short answer for OSPAP pharmacists

You will register as a pharmacist, not a prescriber. OSPAP graduates complete foundation training against modified learning outcomes and join the register without the independent prescribing (IP) annotation.
The gap is closable — faster than most people think. The GPhC abolished the old two-years-of-experience rule in 2022. A registered OSPAP graduate with foundation-year experience can enrol on an accredited IP course, complete roughly six months of part-time study plus at least 90 hours of supervised practice, and gain the same annotation.
Do not wait for the 2028 reform. The GPhC has proposed folding prescribing into a redesigned overseas route — but it is a proposal, consulted on from April 2026, live from 2028 at the earliest. Two extra years outside the UK register costs far more than a post-registration course.

What exactly changed in summer 2026

Under the GPhC's 2021 initial education and training standards, prescribing is no longer a post-registration qualification bolted on years later — it is embedded across the four-year MPharm and the foundation training year, with every trainee supervised by a Designated Prescribing Practitioner (DPP). The first students to go through that entire pipeline qualified this summer. From now on, each year's cohort of newly qualified UK pharmacists arrives on the register able to prescribe independently within their competence.

The GPhC's advice to these new prescribers is telling: it stresses prescribing safely within your competence from day one — a reminder that the annotation is a licence to develop, not a shortcut to expertise. That nuance matters for the job market, as we will see below.

Why the NHS engineered this

The timing is not academic. In England, independent prescribing enters the community pharmacy contract in 2026/27, extending Pharmacy First and the Pharmacy Contraception Service from autumn 2026. The NHS wants community pharmacies to complete treatment episodes — assess, decide, prescribe — without sending patients to a GP. That only works at scale if the workforce can prescribe. The 2021 standards were designed to produce that workforce; summer 2026 is when the tap turns on.

Where OSPAP graduates stand

OSPAP is unaffected in its structure: a one-year accredited postgraduate diploma, followed by foundation training and the registration assessment. What differs is the foundation year's learning outcomes — OSPAP graduates train against a modified set that does not include the full prescribing curriculum, so they register without the annotation.

	UK MPharm graduate (2021 standards)	OSPAP graduate (current route)
Route length	4-year degree + 1 foundation year	1-year OSPAP + foundation training
Prescribing training	Embedded in degree and foundation year	Not included
Status at registration	Pharmacist independent prescriber	Pharmacist (annotation added later)
Route to annotation	Automatic	Accredited post-registration IP course

Two things worth stating plainly. First, this is not a downgrade of OSPAP — nothing has been taken away from the overseas route; the domestic route has moved. Second, the GPhC itself has acknowledged the imbalance: its proposed redesign of the overseas route would include prescribing precisely so that "internationally qualified pharmacists are not disadvantaged on initial registration". That proposal — a single integrated year replacing OSPAP plus foundation training, consulted on from April 2026, possibly in force from 2028 — is covered in full in our analysis of whether OSPAP is being replaced. Until then, nothing changes before September 2026 at the earliest.

Closing the gap: the post-registration IP course

Here is the part most overseas pharmacists have not caught up with: the barriers to the IP course have already fallen. In May 2022 the GPhC scrapped the requirement for two years of post-registration experience in a specific clinical area. Entry to an accredited course now requires:

Relevant experience in a pharmacy setting — and the GPhC explicitly counts experience gained during foundation training and patient-facing clinical work, not just years on the register;
An identified area of clinical practice to base your learning on — hypertension, diabetes, minor ailments, whatever matches your intended role;
A Designated Prescribing Practitioner (DPP) — an experienced prescriber who supervises your minimum 90 hours of learning in practice;
Current registration with the GPhC.

Courses typically run around six months part-time alongside work. Costs vary by university, and funding has been improving as demand rises — NHS England has funded training places in recent cohorts, and a growing number of employers sponsor the course as a retention tool. An OSPAP graduate who registers in summer 2027 can realistically carry the annotation by 2028 — arriving at the same destination as the reformed route would offer, but with a year of UK salary and experience already banked. Overseas prescribing experience, which many OSPAP candidates already have, strengthens both your course application and your choice of clinical area.

Our predictions for 2026–2029

Informed judgement based on the official signals above — not guarantees.

The DPP becomes the real bottleneck. Thousands of pre-2026 registrants and overseas pharmacists will chase the annotation at once, and every one of them needs a DPP for 90 supervised hours. Prescriber supply will lag demand until the first day-one-prescriber cohorts mature into supervisors around 2028–29. Practical consequence: choose your first UK job partly for prescriber access, and secure a DPP commitment early.
Job adverts flip between 2027 and 2028. As Pharmacy First prescribing scales through 2027, "independent prescriber" migrates from desirable to essential on community pharmacist adverts in England — the same drift PCN and GP-practice roles showed years ago. Non-annotated pharmacists will still find work, but increasingly in second-choice settings and locations.
The prescriber premium widens, then narrows. Through 2027–28, annotation will command meaningfully stronger locum rates and faster access to Band 7/8a clinical roles — see our pharmacist salary guide for the current baselines. By around 2030, prescribing will simply be assumed, and the premium fades into the standard rate. The window where the annotation differentiates you is now.
The 2028 overseas-route reform lands late and lands narrow. Regulatory redesigns of this size rarely arrive early. Candidates eligible for OSPAP in 2026/27 who wait for a prescribing-inclusive route are betting two years of UK income on a consultation outcome. The maths does not favour waiting — start with our guide to applying for OSPAP in 2027.

Action plan for OSPAP candidates and students

Check your eligibility and apply — the route is unchanged and universities are recruiting for 2026/27: see OSPAP eligibility requirements and our comparison of OSPAP universities.
Pick a foundation placement with prescribing exposure — a training site with pharmacist prescribers on staff is a future DPP within reach.
Log everything patient-facing — consultations, medication reviews, CPD. Under the post-2022 rules this is exactly the evidence an IP course will assess.
Choose your clinical area early — align it with where you want to work: minor ailments and Pharmacy First conditions for community, a therapeutic specialism for hospital or PCN roles.
Enrol on the IP course within 12–18 months of registering — inside the window where the annotation still commands a premium.

Frequently asked questions

Do OSPAP graduates become independent prescribers when they register?

No. Prescribing at registration applies to graduates trained under the 2021 standards through the MPharm and foundation year. OSPAP graduates register as pharmacists and add the annotation through an accredited post-registration course.

Can OSPAP pharmacists take the prescribing course straight after registration?

Realistically, yes — the two-year experience rule was abolished in 2022. You need relevant pharmacy experience (foundation training counts), a defined clinical area, and a DPP for at least 90 hours of supervised practice.

Will OSPAP include prescribing in the future?

The GPhC has proposed a redesigned single-year overseas route that includes prescribing, consulted on from April 2026 and possibly in place from 2028. It is not yet confirmed, and nothing changes before September 2026 at the earliest.

Does this change make OSPAP a worse option?

No. OSPAP remains the only confirmed route for non-EEA-trained pharmacists, and registering sooner — then adding the annotation — beats waiting years for a reform that may shift. Treat the IP course as part two of the same plan.

Why does the annotation matter so much from autumn 2026?

Because prescribing enters the community pharmacy contract in England in 2026/27 as an extension of Pharmacy First, and the roles built around those services will increasingly expect prescriber-annotated pharmacists.

The profession's entry point has moved, and the smart response for overseas pharmacists is not alarm but sequencing: register through OSPAP on the current rules, then close the prescribing gap inside your first 18 months. For a personal plan covering university choice, costs, foundation placement strategy and the prescribing pathway, book a free consultation with a Global Pathways adviser — or start with our complete guide to registering as a pharmacist in the UK.